BAM Logo

Measurable Residual Disease for CLL by Flow Cytometry (not accredited)

EPTIS factsheet 287270 | Last revision 2022-02-11 | URL: https://www.eptis.bam.de/pts287270 https://www.eptis.bam.de/pts287270

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Remarks Please refer to our website for further information http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/measurable-residual-disease-for-cll-by-flow-cytometry-pilot-not-accredited/
Product groups Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Stabilised whole blood % of residual leukaemic cells Flow cytometry
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards ISO17043:2010 ISO15189:2012 ISO13528:2015
Additional, subsidiary aims
Number of participants 60
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (Maximum 4 per annum)
Year of first operation 2016
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Stuart Scott
Phone: +44 (0) 114 2673600
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5